Short-term caloric restriction, resveratrol, or combined treatment regimens initiated in late-life alter mitochondrial protein expression profiles in a fiber-type specific manner in aged animals

Experimental Gerontology

Volumn 48, Issue 9, 2013, Pages 858-868

  Joseph, Anna Maria ^a   Malamo, Angelina G ^a   Silvestre, Jason ^a   Wawrzyniak, Nick ^a   Carey Love, Sean ^a   Nguyen, Linda M D ^a   Dutta, Debapriya ^a   Xu, Jinze ^a   Leeuwenburgh, Christiaan ^a   Adhihetty, Peter J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aging; Apoptosis; Biogenesis; Caloric restriction; Sarcopenia; Sirtuins

Indexed keywords

APOPTOSIS INDUCING FACTOR; CYTOCHROME C OXIDASE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PROTEIN BAX; PROTEIN BCL 2; RESVERATROL; SIRTUIN 1;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOGENESIS; CALORIC RESTRICTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA FRAGMENTATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG TRANSFORMATION; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; GLYCOLYSIS; INTRACELLULAR SIGNALING; LONGEVITY; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOPENIA; SOLEUS MUSCLE; TREATMENT DURATION; TREATMENT OUTCOME; UPREGULATION;

AGING; APOPTOSIS; BIOGENESIS; CALORIC RESTRICTION; SARCOPENIA; SIRTUINS;

AGING; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALORIC RESTRICTION; COMBINED MODALITY THERAPY; MALE; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; ORGAN SIZE; OXYGEN CONSUMPTION; RATS; RATS, INBRED F344; SARCOPENIA; SIRTUIN 1; STILBENES;

EID: 84880373955     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2013.05.061     Document Type: Article

References (81)

1. Adhihetty P.J., O'Leary M.F., Chabi B., Wicks K.L., Hood D.A. Effect of denervation on mitochondrially mediated apoptosis in skeletal muscle. J. Appl. Physiol. 2007, 102:1143-1151.
2. Adhihetty P.J., Uguccioni G., Leick L., Hidalgo J., Pilegaard H., Hood D.A. The role of PGC-1alpha on mitochondrial function and apoptotic susceptibility in muscle. Am. J. Physiol. Cell Physiol. 2009, 297:C217-C225.
3. Aspnes L.E., Lee C.M., Weindruch R., Chung S.S., Roecker E.B., Aiken J.M. Caloric restriction reduces fiber loss and mitochondrial abnormalities in aged rat muscle. FASEB J. 1997, 11:573-581.
4. Barger J.L., Kayo T., Vann J.M., Arias E.B., Wang J., Hacker T.A., Wang Y., Raederstorff D., Morrow J.D., Leeuwenburgh C., Allison D.B., Saupe K.W., Cartee G.D., Weindruch R., Prolla T.A. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 2008, 3:e2264.
5. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le C.D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de, C.R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
6. Bordone L., Cohen D., Robinson A., Motta M.C., van, V.E., Czopik A., Steele A.D., Crowe H., Marmor S., Luo J., Gu W., Guarente L. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007, 6:759-767.
7. Brasnyo P., Molnar G.A., Mohas M., Marko L., Laczy B., Cseh J., Mikolas E., Szijarto I.A., Merei A., Halmai R., Meszaros L.G., Sumegi B., Wittmann I. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 2011, 106:383-389.
8. Brito P.M., Simoes N.F., Almeida L.M., Dinis T.C. Resveratrol disrupts peroxynitrite-triggered mitochondrial apoptotic pathway: a role for Bcl-2. Apoptosis 2008, 13:1043-1053.
9. Bua E.A., McKiernan S.H., Wanagat J., McKenzie D., Aiken J.M. Mitochondrial abnormalities are more frequent in muscles undergoing sarcopenia. J. Appl. Physiol. 2002, 92:2617-2624.
10. Calvani R., Joseph A.M., Adhihetty P.J., Miccheli A., Bossola M., Leeuwenburgh C., Bernabei R., Marzetti E. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol. Chem. 2013, 394:393-414.
11. Canto C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., Elliott P.J., Puigserver P., Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
12. Chabi B., Ljubicic V., Menzies K.J., Huang J.H., Saleem A., Hood D.A. Mitochondrial function and apoptotic susceptibility in aging skeletal muscle. Aging Cell 2008, 7:2-12.
13. Cohen H.Y., Miller C., Bitterman K.J., Wall N.R., Hekking B., Kessler B., Howitz K.T., Gorospe M., de, C.R., Sinclair D.A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004, 305:390-392.
14. Crandall J.P., Oram V., Trandafirescu G., Reid M., Kishore P., Hawkins M., Cohen H.W., Barzilai N. Pilot study of resveratrol in older adults with impaired glucose tolerance. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:1307-1312.
15. Das S., Lin H.S., Ho P.C., Ng K.Y. The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol. Pharm. Res. 2008, 25:2593-2600.
16. Dasgupta B., Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:7217-7222.
17. Dirks A., Leeuwenburgh C. Apoptosis in skeletal muscle with aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R519-R527.
18. Dirks A.J., Leeuwenburgh C. Aging and lifelong calorie restriction result in adaptations of skeletal muscle apoptosis repressor, apoptosis-inducing factor, X-linked inhibitor of apoptosis, caspase-3, and caspase-12. Free Radic. Biol. Med. 2004, 36:27-39.
19. Dirks A.J., Leeuwenburgh C. The role of apoptosis in age-related skeletal muscle atrophy. Sports Med. 2005, 35:473-483.
20. Dirks A.J., Leeuwenburgh C. Caloric restriction in humans: potential pitfalls and health concerns. Mech. Ageing Dev. 2006, 127:1-7.
21. Egan D.F., Shackelford D.B., Mihaylova M.M., Gelino S., Kohnz R.A., Mair W., Vasquez D.S., Joshi A., Gwinn D.M., Taylor R., Asara J.M., Fitzpatrick J., Dillin A., Viollet B., Kundu M., Hansen M., Shaw R.J. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331:456-461.
22. Frye R.A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 1999, 260:273-279.
23. Gonzalez A.A., Kumar R., Mulligan J.D., Davis A.J., Weindruch R., Saupe K.W. Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E1032-E1037.
24. Guarente L., Picard F. Calorie restriction-the SIR2 connection. Cell 2005, 120:473-482.
25. Harman D. The free radical theory of aging. Antioxid. Redox Signal. 2003, 5:557-561.
26. Hood D.A. Invited review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J. Appl. Physiol. 2001, 90:1137-1157.
27. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
28. Irrcher I., Ljubicic V., Kirwan A.F., Hood D.A. AMP-activated protein kinase-regulated activation of the PGC-1alpha promoter in skeletal muscle cells. PLoS One 2008, 3:e3614.
29. Jackson J.R., Ryan M.J., Hao Y., Alway S.E. Mediation of endogenous antioxidant enzymes and apoptotic signaling by resveratrol following muscle disuse in the gastrocnemius muscles of young and old rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R1572-R1581.
30. Jackson J.R., Ryan M.J., Alway S.E. Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66:751-764.
31. Jager S., Handschin C., St-Pierre J., Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12017-12022.
32. Joseph A.M., Adhihetty P.J., Buford T.W., Wohlgemuth S.E., Lees H.A., Nguyen L.M., Aranda J.M., Sandesara B.D., Pahor M., Manini T.M., Marzetti E., Leeuwenburgh C. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals. Aging Cell 2012, 11:801-809.
33. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13:132-141.
34. Knutson M.D., Leeuwenburgh C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr. Rev. 2008, 66:591-596.
35. Koubova J., Guarente L. How does calorie restriction work?. Genes Dev. 2003, 17:313-321.
36. Kuznetsov A.V., Wiedemann F.R., Winkler K., Kunz W.S. Use of saponin-permeabilized muscle fibers for the diagnosis of mitochondrial diseases. Biofactors 1998, 7:221-223.
37. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
38. Lee C.M., Aspnes L.E., Chung S.S., Weindruch R., Aiken J.M. Influences of caloric restriction on age-associated skeletal muscle fiber characteristics and mitochondrial changes in rats and mice. Ann. N. Y. Acad. Sci. 1998, 854:182-191.
39. Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., Tsokos M., Alt F.W., Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3374-3379.
40. Lee J.W., Park S., Takahashi Y., Wang H.G. The association of AMPK with ULK1 regulates autophagy. PLoS One 2010, 5:e15394.
41. Lexell J. Effects of strength and endurance training on skeletal muscles in the elderly. New muscles for old!. Lakartidningen 1999, 96:207-209.
42. Lin J., Wu H., Tarr P.T., Zhang C.Y., Wu Z., Boss O., Michael L.F., Puigserver P., Isotani E., Olson E.N., Lowell B.B., Bassel-Duby R., Spiegelman B.M. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002, 418:797-801.
43. Marzetti E., Carter C.S., Wohlgemuth S.E., Lees H.A., Giovannini S., Anderson B., Quinn L.S., Leeuwenburgh C. Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech. Ageing Dev. 2009, 130:272-280.
44. Marzetti E., Lees H.A., Wohlgemuth S.E., Leeuwenburgh C. Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 2009, 35:28-35.
45. Masiero E., Sandri M. Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles. Autophagy 2010, 6:307-309.
46. McBurney M.W., Yang X., Jardine K., Bieman M., Th'ng J., Lemieux M. The absence of SIR2alpha protein has no effect on global gene silencing in mouse embryonic stem cells. Mol. Cancer Res. 2003, 1:402-409.
47. McKenzie D., Bua E., McKiernan S., Cao Z., Aiken J.M. Mitochondrial DNA deletion mutations: a causal role in sarcopenia. Eur. J. Biochem. 2002, 269:2010-2015.
48. McKiernan S.H., Bua E., McGorray J., Aiken J. Early-onset calorie restriction conserves fiber number in aging rat skeletal muscle. FASEB J. 2004, 18:580-581.
49. Migliore L., Coppede F. Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat. Res. 2002, 512:135-153.
50. Morselli E., Maiuri M.C., Markaki M., Megalou E., Pasparaki A., Palikaras K., Criollo A., Galluzzi L., Malik S.A., Vitale I., Michaud M., Madeo F., Tavernarakis N., Kroemer G. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 2010, 1:e10.
51. Muller F.L., Song W., Liu Y., Chaudhuri A., Pieke-Dahl S., Strong R., Huang T.T., Epstein C.J., Roberts L.J., Csete M., Faulkner J.A., Van R.H. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 2006, 40:1993-2004.
52. Murase T., Haramizu S., Ota N., Hase T. Suppression of the aging-associated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice. Biogerontology 2009, 10:423-434.
53. Nemoto S., Fergusson M.M., Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J. Biol. Chem. 2005, 280:16456-16460.
54. Pansarasa O., Bertorelli L., Vecchiet J., Felzani G., Marzatico F. Age-dependent changes of antioxidant activities and markers of free radical damage in human skeletal muscle. Free Radic. Biol. Med. 1999, 27:617-622.
55. Pearson K.J., Baur J.A., Lewis K.N., Peshkin L., Price N.L., Labinskyy N., Swindell W.R., Kamara D., Minor R.K., Perez E., Jamieson H.A., Zhang Y., Dunn S.R., Sharma K., Pleshko N., Woollett L.A., Csiszar A., Ikeno Y., Le Couteur D., Elliott P.J., Becker K.G., Navas P., Ingram D.K., Wolf N.S., Ungvari Z., Sinclair D.A., de Cabo R. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008, 8:157-168.
56. Phillips T., Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J. 2005, 19:668-670.
57. Pistilli E.E., Alway S.E. Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats. Biochem. Biophys. Res. Commun. 2008, 373:20-24.
58. Pistilli E.E., Jackson J.R., Alway S.E. Death receptor-associated pro-apoptotic signaling in aged skeletal muscle. Apoptosis 2006, 11:2115-2126.
59. Price N.L., Gomes A.P., Ling A.J., Duarte F.V., Martin-Montalvo A., North B.J., Agarwal B., Ye L., Ramadori G., Teodoro J.S., Hubbard B.P., Varela A.T., Davis J.G., Varamini B., Hafner A., Moaddel R., Rolo A.P., Coppari R., Palmeira C.M., de Cabo R., Baur J.A., Sinclair D.A. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012, 15:675-690.
60. Proctor D.N., Sinning W.E., Walro J.M., Sieck G.C., Lemon P.W. Oxidative capacity of human muscle fiber types: effects of age and training status. J. Appl. Physiol. 1995, 78:2033-2038.
61. Qiu X., Brown K., Hirschey M.D., Verdin E., Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010, 12:662-667.
62. Rice K.M., Blough E.R. Sarcopenia-related apoptosis is regulated differently in fast- and slow-twitch muscles of the aging F344/N×BN rat model. Mech. Ageing Dev. 2006, 127:670-679.
63. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
64. Rooyackers O.E., Adey D.B., Ades P.A., Nair K.S. Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:15364-15369.
65. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J. Nutr. 1997, 127:990S-991S.
66. Ryan M.J., Jackson J.R., Hao Y., Williamson C.L., Dabkowski E.R., Hollander J.M., Alway S.E. Suppression of oxidative stress by resveratrol after isometric contractions in gastrocnemius muscles of aged mice. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65:815-831.
67. Ryter S.W., Kim H.P., Nakahira K., Zuckerbraun B.S., Morse D., Choi A.M. Protective functions of heme oxygenase-1 and carbon monoxide in the respiratory system. Antioxid. Redox Signal. 2007, 9:2157-2173.
68. Short K.R., Bigelow M.L., Kahl J., Singh R., Coenen-Schimke J., Raghavakaimal S., Nair K.S. Decline in skeletal muscle mitochondrial function with aging in humans. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5618-5623.
69. Siu P.M., Pistilli E.E., Alway S.E. Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading. J. Appl. Physiol. 2008, 105:1695-1705.
70. Speakman J.R., Mitchell S.E. Caloric restriction. Mol. Aspects Med. 2011, 32:159-221.
71. Suwa M., Nakano H., Kumagai S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J. Appl. Physiol. 2003, 95:960-968.
72. Tanno M., Kuno A., Yano T., Miura T., Hisahara S., Ishikawa S., Shimamoto K., Horio Y. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 2010, 285:8375-8382.
73. Timmers S., Konings E., Bilet L., Houtkooper R.H., van de Weijer T., Goossens G.H., Hoeks J., van der Krieken S., Ryu D., Kersten S., Moonen-Kornips E., Hesselink M.K., Kunz I., Schrauwen-Hinderling V.B., Blaak E.E., Auwerx J., Schrauwen P. Calorie restriction-like effects of 30days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011, 14:612-622.
74. To K., Yamaza H., Komatsu T., Hayashida T., Hayashi H., Toyama H., Chiba T., Higami Y., Shimokawa I. Down-regulation of AMP-activated protein kinase by calorie restriction in rat liver. Exp. Gerontol. 2007, 42:1063-1071.
75. Um J.H., Park S.J., Kang H., Yang S., Foretz M., McBurney M.W., Kim M.K., Viollet B., Chung J.H. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59:554-563.
76. Valenzano D.R., Terzibasi E., Genade T., Cattaneo A., Domenici L., Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 2006, 16:296-300.
77. Wenz T., Rossi S.G., Rotundo R.L., Spiegelman B.M., Moraes C.T. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20405-20410.
78. Whitman S.A., Wacker M.J., Richmond S.R., Godard M.P. Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age. Pflugers Arch. 2005, 450:437-446.
79. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
80. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., Spiegelman B.M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
81. Wyke S.M., Russell S.T., Tisdale M.J. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. Br. J. Cancer 2004, 91:1742-1750.